Hydrophobic binding peptide-conjugated hybrid lipid-mesoporous silica nanoparticles for effective chemo-photothermal therapy of pancreatic cancer

References

• Biswas S, Dodwadkar NS, Sawant RR, Torchilin VP. (2011). Development of the novel PEG-PE-based polymer for the reversible attachment of specific ligands to liposomes: synthesis and in vitro characterization. Bioconjugate Chem 22:2005–13.
   PubMed Web of Science ®Google Scholar
• Bolhassani A. (2011). Potential efficacy of cell-penetrating peptides for nucleic acid and drug delivery in cancer. Biochim Biophys Acta 1816:232–46.
   PubMed Web of Science ®Google Scholar
• Cai D, Gao W, He B, et al. (2014). Hydrophobic penetrating peptide PFVYLI-modified stealth liposomes for doxorubicin delivery in breast cancer therapy. Biomaterials 35:2283–94.
   PubMed Web of Science ®Google Scholar
• Castillo RR, Colilla M, Vallet-Regí M. (2017). Advances in mesoporous silica-based nanocarriers for co-delivery and combination therapy against cancer. Exp Opin Drug Deliv 14:229–43.
   PubMed Web of Science ®Google Scholar
• Choi JH, Lee YJ, Kim D. (2017). Image-guided nanomedicine for cancer. J Pharm Investig 47:51–64.
   Google Scholar
• Choi JY, Thapa RK, Yong CS, Kim JO. (2016). Nanoparticle-based combination drug delivery systems for synergistic cancer treatment. J Pharm Investig 46:325–39.
   Google Scholar
• Fernandez-Fernandez A, Manchanda R, Carvajal DA, et al. (2014). Covalent IR820-PEG-diamine nanoconjugates for theranostic applications in cancer. Int J Nanomed 9:4631–48.
   PubMed Web of Science ®Google Scholar
• Fernandez-Fernandez A, Manchanda R, Lei T, et al. (2012). Comparative study of the optical and heat generation properties of IR820 and Indocyanine Green. Mol Imaging 11:99–113.
   PubMed Web of Science ®Google Scholar
• Gao W, Yang X, Lin Z, et al. (2016). The use of a hydrophobic binding peptide modified lipid nanocarrier improving tumor distribution and antitumor efficacy. J Biomed Nanotechnol 12:1183–98.
   PubMed Web of Science ®Google Scholar
• Ilic M, Ilic I. (2016). Epidemiology of pancreatic cancer. World J Gastroenterol 22:9694–705.
   PubMed Web of Science ®Google Scholar
• Jemal A, Siegel R, Xu J, Ward E. (2010). Cancer Statistics, 2010. Cancer J Clin 60:277–300.
   PubMed Web of Science ®Google Scholar
• Jia F, Liu X, Li L, et al. (2013). Multifunctional nanoparticles for targeted delivery of immune activating and cancer therapeutic agents. J Control Release 172:1020–34.
   PubMed Web of Science ®Google Scholar
• Jones AT, Sayers EJ. (2012). Cell entry of cell penetrating peptides: tales of tails wagging dogs. J Control Release 161:582–91.
   PubMed Web of Science ®Google Scholar
• Kilk K, Mahlapuu R, Soomets U, Langel Ü. (2009). Analysis of in vitro toxicity of five cell-penetrating peptides by metabolic profiling. Toxicology 265:87–95.
   PubMed Web of Science ®Google Scholar
• Kim JS. (2016). Liposomal drug delivery system. J Pharm Investig 46:387–92.
   Google Scholar
• Kleeff J, Reiser C, Hinz U, et al. (2007). Surgery for recurrent pancreatic ductal adenocarcinoma. Ann Surg 245:566–72.
   PubMed Web of Science ®Google Scholar
• Lei T, Fernandez-Fernandez A, Manchanda R, et al. (2014). Near-infrared dye loaded polymeric nanoparticles for cancer imaging and therapy and cellular response after laser-induced heating. Beilstein J Nanotechnol 5:313–22.
   PubMed Web of Science ®Google Scholar
• Li M, Deng H, Peng H, Wang Q. (2014). Functional nanoparticles in targeting glioma diagnosis and therapies. J Nanosci Nanotech 14:415–32.
   PubMed Web of Science ®Google Scholar
• Lu Z-R, Gao S-Q, Kopečková P, Kopeček J. (2001). Modification of cyclosporin A and conjugation of its derivative to HPMA copolymers. Bioconjug Chem 12:129–33.
   PubMed Web of Science ®Google Scholar
• Meyer EE, Rosenberg KJ, Israelachvili J. (2006). Recent progress in understanding hydrophobic interactions. Proc Natl Acad Sci USA 103:15739–46.
   PubMed Web of Science ®Google Scholar
• Mini E, Nobili S, Caciagli B, et al. (2006). Cellular pharmacology of gemcitabine. Ann Oncol 17:v7–v12.
   PubMed Web of Science ®Google Scholar
• Ramasamy T, Haidar ZS, Tran TH, et al. (2014). Layer-by-layer assembly of liposomal nanoparticles with PEGylated polyelectrolytes enhances systemic delivery of multiple anticancer drugs. Acta Biomater 10:5116–27.
   PubMed Web of Science ®Google Scholar
• Rezai T, Yu B, Millhauser GL, et al. (2006). Testing the conformational hypothesis of passive membrane permeability using synthetic cyclic peptide diastereomers. J Am Chem Soc 128:2510–11.
   PubMed Web of Science ®Google Scholar
• Saar K, Lindgren M, Hansen M, et al. (2005). Cell-penetrating peptides: a comparative membrane toxicity study. Anal Biochem 345:55–65.
   PubMed Web of Science ®Google Scholar
• Tedesco D, Haragsim L. (2012). Cyclosporine: a review. J Transplant 2012:230386.
   PubMedGoogle Scholar
• Thapa RK, Choi JY, Poudel BK, et al. (2015). Multilayer-coated liquid crystalline nanoparticles for effective sorafenib delivery to hepatocellular carcinoma. ACS Appl Mater Interfaces 7:20360–8.
   PubMed Web of Science ®Google Scholar
• Thapa RK, Nguyen HT, Jeong J-H, et al. (2017). Synergistic anticancer activity of combined histone deacetylase and proteasomal inhibitor-loaded zein nanoparticles in metastatic prostate cancers. Nanomed Nanotech Biol Med 13:885–96.
   PubMed Web of Science ®Google Scholar
• Thapa RK, Youn YS, Jeong J-H, et al. (2016). Graphene oxide-wrapped PEGylated liquid crystalline nanoparticles for effective chemo-photothermal therapy of metastatic prostate cancer cells. Colloids Surf B Biointerfaces 143:271–7.
   PubMed Web of Science ®Google Scholar
• Trachootham D, Alexandre J, Huang P. (2009). Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Discov 8:579–91.
   PubMed Web of Science ®Google Scholar
• Vyas D, Castro P, Saadeh Y, Vyas A. (2014). The role of nanotechnology in gastrointestinal cancer. J Biomed Nanotechnol 10:3204–18.
   PubMed Web of Science ®Google Scholar
• Wang Y, Wang K, Zhang R, et al. (2014). Synthesis of core–shell graphitic carbon@silica nanospheres with dual-ordered mesopores for cancer-targeted photothermochemotherapy. ACS Nano 8:7870–9.
   PubMed Web of Science ®Google Scholar
• Watkins CL, Brennan P, Fegan C, et al. (2009). Cellular uptake, distribution and cytotoxicity of the hydrophobic cell penetrating peptide sequence PFVYLI linked to the proapoptotic domain peptide PAD. J Control Release 140:237–44.
   PubMed Web of Science ®Google Scholar
• Yao VJ, D’Angelo S, Butler KS, et al. (2016). Ligand-targeted theranostic nanomedicines against cancer. J Control Release 240:267–86.
   PubMed Web of Science ®Google Scholar
• Zhang L, Gu FX, Chan JM, et al. (2008). Nanoparticles in medicine: therapeutic applications and developments. Clin Pharmacol Ther 83:761–9.
   PubMed Web of Science ®Google Scholar
• Zhou H, Hou X, Liu Y, et al. (2016). Superstable Magnetic Nanoparticles in Conjugation with Near-Infrared Dye as a Multimodal Theranostic Platform. ACS Appl Mater Interfaces 8:4424–33.
   PubMed Web of Science ®Google Scholar
• Zhou P, Li B, Liu F, et al. (2017). The epithelial to mesenchymal transition (EMT) and cancer stem cells: implication for treatment resistance in pancreatic cancer. Mol Cancer 16:52.
   PubMed Web of Science ®Google Scholar